Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FH0T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,658
Award facts
- Contract value 100% obligated
- $2,658.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a contract ceiling value of $2,658.26. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle that extends through December 2026 and supports military healthcare systems globally.
AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical distributor and healthcare solutions provider, supplying a broad portfolio of medications and medical supplies to the Department of Defense and related military healthcare programs. The company's contract history demonstrates extensive capability in fulfilling federal medical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The Zepbound delivery order represents a discrete transaction within the company's ongoing DLA pharmaceutical support mission, enabling continued access to this diabetes medication for federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FH0T3?
SPE2DB25FH0T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FH0T3 worth?
The government has obligated $2,658 on SPE2DB25FH0T3.
Is contract SPE2DB25FH0T3 an order under another contract?
Yes. SPE2DB25FH0T3 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH0T3 competed?
The extent of competition for SPE2DB25FH0T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award